ERICK BROWN: Open Payments
NPI 1689834335 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 97 payments from 16 companies in 2025. Trend: 2023 $1,543 · 2024 $1,525 · 2025 $1,697
Food & beverage: $1,697
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $344 |
| Otsuka America Pharmaceutical, Inc. | 19 | $286 |
| Vanda Pharmaceuticals Inc. | 5 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $136 |
| Axsome Therapeutics, Inc. | 7 | $111 |
| Neurocrine BioSciences, Inc. | 5 | $109 |
| Lundbeck LLC | 5 | $93 |
| Janssen Pharmaceuticals, Inc | 5 | $85 |
| Supernus Pharmaceuticals, Inc. | 4 | $78 |
| Collegium Pharmaceutical, Inc. | 4 | $74 |
Products named: VRAYLAR, REXULTI, HETLIOZ, CAPLYTA, Auvelity, INGREZZA, SPRAVATO, Qelbree.
Industry payments across KS — which companies pay providers there.
